Cargando…

Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients

The p27(Kip1) gene has been identified as inductor of cell cycle arrest at the G1 checkpoint to prevent entry of somatic cells into the S phase of the cell cycle when substantial DNA damage has occurred. It has been suggested that decreased expression of the p27(Kip1) protein may contribute to the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuczyk, M, Machtens, S, Hradil, K, Schubach, J, Christian, W, Knüchel, R, Hartmann, J, Bokemeyer, C, Jonas, U, Serth, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362945/
https://www.ncbi.nlm.nih.gov/pubmed/10576664
http://dx.doi.org/10.1038/sj.bjc.6690806
_version_ 1782153580400082944
author Kuczyk, M
Machtens, S
Hradil, K
Schubach, J
Christian, W
Knüchel, R
Hartmann, J
Bokemeyer, C
Jonas, U
Serth, J
author_facet Kuczyk, M
Machtens, S
Hradil, K
Schubach, J
Christian, W
Knüchel, R
Hartmann, J
Bokemeyer, C
Jonas, U
Serth, J
author_sort Kuczyk, M
collection PubMed
description The p27(Kip1) gene has been identified as inductor of cell cycle arrest at the G1 checkpoint to prevent entry of somatic cells into the S phase of the cell cycle when substantial DNA damage has occurred. It has been suggested that decreased expression of the p27(Kip1) protein may contribute to the development of human malignancies due to loss of critical antiproliferative mechanisms. In the present study, 95 specimens (T1–T4) from 95 randomly selected patients undergoing radical prostatectomy at the Urological Department of Hannover University (82 patients) as well as in the Josef Hospital Regensburg (13 patients) between 1981 and 1992 for whom tissue blocks for immunohistochemical investigation were available, were investigated for different biological and clinical characteristics as possible predictors for recurrence-free and long-term survival: age, depth of tumour infiltration, histological grade, lymph node status, as well as decreased expression of the p27(Kip1) protein. After a median follow-up up of 56 months (24–151 months), seven of 21 (33%) patients (Group 1) with loss of p27(Kip1) protein expression or a relative amount of <10% of positively stained tumour cells developed recurrent disease in contrast to 17 of 74 (23%) patients (Group 2) with retained p27(Kip1) protein expression (≥10% of positively stained tumour cells). The median recurrence-free survival was 14 months (5–40 months) for patients from Group 1 and 31 months (7–133 months) for Group 2 patients (P = 0.02). In multivariate analysis, loss of p27(Kip1) protein expression was identified as the only independent prognostic parameter for recurrence-free survival. In contrast, neither the univariate nor the multivariate analysis showed a correlation between loss of p27(Kip1) protein expression and the long-term survival of the patients. Prospective studies are urgently needed to confirm the independent prognostic value of decreased p27(Kip1) protein expression together with overexpression of the p53 tumour suppressor protein in patients with localized prostate cancer. The availability of more refined prognostically important biological variables in addition to established prognostic factors like tumour stage or Gleason score might help decision making in patients at high risk for the development of local recurrence or systemic tumour progression. © 1999 Cancer Research Campaign
format Text
id pubmed-2362945
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23629452009-09-10 Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients Kuczyk, M Machtens, S Hradil, K Schubach, J Christian, W Knüchel, R Hartmann, J Bokemeyer, C Jonas, U Serth, J Br J Cancer Regular Article The p27(Kip1) gene has been identified as inductor of cell cycle arrest at the G1 checkpoint to prevent entry of somatic cells into the S phase of the cell cycle when substantial DNA damage has occurred. It has been suggested that decreased expression of the p27(Kip1) protein may contribute to the development of human malignancies due to loss of critical antiproliferative mechanisms. In the present study, 95 specimens (T1–T4) from 95 randomly selected patients undergoing radical prostatectomy at the Urological Department of Hannover University (82 patients) as well as in the Josef Hospital Regensburg (13 patients) between 1981 and 1992 for whom tissue blocks for immunohistochemical investigation were available, were investigated for different biological and clinical characteristics as possible predictors for recurrence-free and long-term survival: age, depth of tumour infiltration, histological grade, lymph node status, as well as decreased expression of the p27(Kip1) protein. After a median follow-up up of 56 months (24–151 months), seven of 21 (33%) patients (Group 1) with loss of p27(Kip1) protein expression or a relative amount of <10% of positively stained tumour cells developed recurrent disease in contrast to 17 of 74 (23%) patients (Group 2) with retained p27(Kip1) protein expression (≥10% of positively stained tumour cells). The median recurrence-free survival was 14 months (5–40 months) for patients from Group 1 and 31 months (7–133 months) for Group 2 patients (P = 0.02). In multivariate analysis, loss of p27(Kip1) protein expression was identified as the only independent prognostic parameter for recurrence-free survival. In contrast, neither the univariate nor the multivariate analysis showed a correlation between loss of p27(Kip1) protein expression and the long-term survival of the patients. Prospective studies are urgently needed to confirm the independent prognostic value of decreased p27(Kip1) protein expression together with overexpression of the p53 tumour suppressor protein in patients with localized prostate cancer. The availability of more refined prognostically important biological variables in addition to established prognostic factors like tumour stage or Gleason score might help decision making in patients at high risk for the development of local recurrence or systemic tumour progression. © 1999 Cancer Research Campaign Nature Publishing Group 1999-11 /pmc/articles/PMC2362945/ /pubmed/10576664 http://dx.doi.org/10.1038/sj.bjc.6690806 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Kuczyk, M
Machtens, S
Hradil, K
Schubach, J
Christian, W
Knüchel, R
Hartmann, J
Bokemeyer, C
Jonas, U
Serth, J
Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title_full Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title_fullStr Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title_full_unstemmed Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title_short Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
title_sort predictive value of decreased p27(kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362945/
https://www.ncbi.nlm.nih.gov/pubmed/10576664
http://dx.doi.org/10.1038/sj.bjc.6690806
work_keys_str_mv AT kuczykm predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT machtenss predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT hradilk predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT schubachj predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT christianw predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT knuchelr predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT hartmannj predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT bokemeyerc predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT jonasu predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients
AT serthj predictivevalueofdecreasedp27kip1proteinexpressionfortherecurrencefreeandlongtermsurvivalofprostatecancerpatients